PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2005BJOG An International Journal of Obstetrics & Gynaecology112 citations

An accurate automated blood pressure device for use in pregnancy and pre‐eclampsia: the Microlife 3BTO‐A

ARAnnemarie ReindersACA C CucksonJLJ.T.M Lee

Key Result

The Microlife 3BTO-A automated blood pressure device passed the British Hypertension Society protocol by achieving an overall grade A for systolic and grade B for diastolic pressures in pregnant women.

Study Design

Type

Observational (n=105)

Multicenter

Yes

Structured PICO

Does the Microlife 3BTO-A automated blood pressure device accurately measure blood pressure compared to a mercury sphygmomanometer in pregnant women, including those with pre-eclampsia?

P
Population
105 pregnant women, including 35 with non-proteinuric hypertension and 35 with pre-eclampsia
I
Intervention
Automated blood pressure device (Microlife 3BTO-A)
C
Comparator
Mercury sphygmomanometer
O
Outcome
Grading criteria of the British Hypertension Society (BHS) protocol (A/B grade = pass; C/D grade = fail)surrogate

The Microlife 3BTO-A automated blood pressure device is accurate and meets BHS and AAMI criteria for use in pregnant women, including those with pre-eclampsia.

Limitations

  • The device showed greater error in pre-eclampsia compared with normotensive pregnancy.

Abstract

OBJECTIVE: To assess the accuracy of an automated blood pressure device (Microlife 3BTO-A) in pregnancy and pre-eclampsia according to the British Hypertension Society (BHS) protocol. DESIGN: Prospective observational study. SETTING: Antenatal ward and clinics at Guy's and St Thomas' Hospital, London, UK. POPULATION: One hundred and five pregnant women including 35 women with non-proteinuric hypertension and 35 with pre-eclampsia. METHODS: Two trained observers took nine sequential same-arm measurements from each woman. Measurements alternated between a mercury sphygmomanometer and the device. MAIN OUTCOME MEASURES: Grading criteria of the BHS protocol (A/B grade = pass; C/D grade = fail). RESULTS: The device passed the BHS protocol by achieving an A/B grade. It also achieved criteria of the Association for the Advancement of Medical Instrumentation for systolic and diastolic pressures respectively, in normotensive -0.5 (5.7) mmHg; -0.07 (7.7) mmHg, non-proteinuric hypertensive -3.3 (6.9) mmHg; -2.4 (6.6) mmHg and pre-eclamptic pregnancy -4.1 (6.4) mmHg; -1.3 (7.9) mmHg. CONCLUSION: The Microlife 3BTO-A can be recommended for use in a pregnant population, including pre-eclampsia, according to the BHS protocol.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Reinders et al. (2005) conducted an observational in Pregnancy, non-proteinuric hypertension, and pre-eclampsia (n=105). Microlife 3BTO-A vs. Mercury sphygmomanometer was evaluated on Grading criteria of the British Hypertension Society (BHS) protocol. The Microlife 3BTO-A automated blood pressure device passed the British Hypertension Society protocol by achieving an overall grade A for systolic and grade B for diastolic pressures in pregnant women.

synapsesocial.com/papers/6a13fe783f92ec2dd7599879https://doi.org/10.1111/j.1471-0528.2005.00617.x
Ask AI
Helpful
Bookmark
Share
View Full Paper